Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Marsh & Mclennan Companies (MRSH) EBT (2016 - 2026)

Marsh & Mclennan Companies filings provide 18 years of EBT readings, the most recent being $1.6 billion for Q1 2026.

  • On a quarterly basis, EBT fell 13.46% to $1.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $5.3 billion, a 2.63% decrease, with the full-year FY2025 number at $5.5 billion, up 1.08% from a year prior.
  • EBT reached $1.6 billion in Q1 2026 per MRSH's latest filing, up from $1.1 billion in the prior quarter.
  • The five-year high for EBT was $1.9 billion in Q1 2024, with the low at $613.0 million in Q4 2022.
  • A 5-year average of $1.3 billion and a median of $1.3 billion in 2022 define the central range for EBT.
  • Year-over-year, EBT plummeted 36.21% in 2022 and then skyrocketed 70.96% in 2023.
  • Year by year, EBT stood at $613.0 million in 2022, then skyrocketed by 70.96% to $1.0 billion in 2023, then fell by 3.72% to $1.0 billion in 2024, then increased by 4.66% to $1.1 billion in 2025, then soared by 49.72% to $1.6 billion in 2026.
  • Per Business Quant, the three most recent readings for MRSH's EBT are $1.6 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.0 billion (Q3 2025).